Domaine de recherche et d’Innovation Majeur (DIM) BioConvergence pour la Santé - Call 2023 - II / PhD fellowships
BioConvergence pour la Santé (BioConvS) is a “Domaine d'Intérêt Majeur” (DIM) initiative from the Région Ile-de-France which aims to structure the synthetic biology, biotherapy and bioproduction communities, to guide the transition from scientific excellence to innovation, and to position Île-de-France region as an international reference in the domain.
BioConvS is led by Université Paris Cité in partnership with Sorbonne University, Curie Institute - PSL, Micalis Institute (INRAe, AgroParisTech, Saclay University), INSERM, Généthon, Génopole and others. BioConvS groups actors from the public and private sectors and benefits from 12.5M€ support from the Ile de France Region. More details about DIM BioConvS on: https://bioconvs.org/
About the call
This call will finance four PhD fellowships on projects in line with one of the DIM BioConvS' thematic axes:
Bioengineering and bioproduction
Development of therapeutic proofs of principle
New, high throughput and standardizable analytical methods
Digital or AI tools to improve data analysis or modeling in quality control and production methods
Ensure a responsible, ethical and inclusive Bioconvergence
It is open from March 22nd to May 31st, 2023. Only theses supervised by at least two teams (the second team can be a company) located in Ile-de-France are eligible for this call.
Additional teams may participate in the project to provide additional specific expertise without geographical limitation. Teams outside the Ile-de-France region will not be funded.
As indicated above, start-ups and companies from the Ile de France region can also be associated with the project but will not be funded under this call. Participation in a company project will be a plus.
Projects must be written in English, but a summary in French is required.
Loading... 
